OOIR: Observatory of International Research

Papers

(The median citation count of Critical Reviews in Microbiology is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)

Article	Citations
Male-specific bacteriophages and their potential on combating the spreading of T4SS-bearing antimicrobial resistance plasmids	132
Dynamics of antibiotic resistance genes in plasmids and bacteriophages	70
TREM-2: friend or foe in infectious diseases?	64
Neuroinflammation-mediated relationship between oral microbiome and neurodegenerative diseases	61
Salmonella in eggs and egg-laying chickens: pathways to effective control	52
Host and bacterial lipid metabolism during tuberculosis infections: possibilities to synergise host- and bacteria-directed therapies	46
Paving the way forward: Escherichia coli bacteriophages in a One Health approach	44
Engineered probiotics as live biotherapeutics for diagnosis and treatment of human diseases	43
Antimicrobial peptides as promising antibiotic adjuvants to combat drug-resistant pathogens	42
Current and emerging therapies for fungal biofilms and systemic infections	42
Outer membrane proteins and vesicles as promising vaccine candidates against Vibrio spp. infections	41
Elucidating the multifaceted antibacterial mechanisms of luteolin: insights, challenges, and prospects for clinical translation	34
Antibiotic heteroresistance: an important factor in the failure of Helicobacter Pylori eradication	32
Targeting bioinformatics tools to study the dissemination and spread of antibiotic resistant genes in the environment and clinical settings	30
Under the lens: using Raman spectroscopy as a unique system in biofilm analyses	30
LysR-type transcriptional regulators: state of the art	29
Exploring halophilic environments as a source of new antibiotics	27
Interplay between Clostridioides difficile infection, host immunity, and metabolism: a comprehensive review	27
The crosstalk between gut microbiota and microbiota-derived metabolites in hepatocellular carcinoma	26
Helicobacter pylori ’s secret resilience: coccoid forms, yeast havens, and outer membrane vesicle release for survival and spread	25
Vibrio cholerae virulence and its suppression through the quorum-sensing system	24
Anti- Candida albicans natural products: convergent technologies revolutionizing discovery from bioactivity assessment to targeted mechanisms	23
Helicobacter pylori eradication: developing antibiotic-independent antimicrobial moieties	22
Bacterial vaginosis: advancing insights into microbial dysbiosis	22
Polyamine as a microenvironment factor in resistance to antibiotics	22

Advances in the applications of Bacteriophages and phage products against food-contaminating bacteria	22
The role of single and mixed biofilms in Clostridioides difficile infection and strategies for prevention and inhibition	22
The diffusible signaling factor family in microbial signaling: a current perspective	21
Endophytic fungi-bioinspired nanoparticles potential to control infectious disease	21
Recent advances in omics-driven research of photosynthetic microorganisms in green biotechnology	20
Probiotics for pancreatic β-cell function: from possible mechanism of action to assessment of effectiveness	20
Molecular mechanisms of Klebsiella pneumoniae pathogenicity: from virulence factors to emerging therapeutic strategies	19
Emergence of persister cells in Staphylococcus aureus : calculated or fortuitous move?	19
Antibiotic resistance in Pseudomonas aeruginosa : mechanisms and emerging treatment	18
Emerging strategies to target virulence in Pseudomonas aeruginosa respiratory infections	18
Microbial persisters and host: recent advances and future perspectives	17
Revisiting the antimicrobial potential of metalloporphyrins: from food to pharma	17
Microbial biosynthesis of nucleos(t)ide analogs: applications, and engineering optimization	17
The resilient microbiome: how baseline gut microbial composition influences response to cancer treatment	17
Biotherapeutic potential of gut microbiota-derived indole-3-acetic acid	17
Quorum sensing in biofilms: a key mechanism to target in ecotoxicological studies	16
Ureaplasma infections: update on epidemiology, antimicrobial resistance, and pathogenesis	16
Current types of staphylococcal cassette chromosome mec (SCC mec ) in clinically relevant coagulase-negative staphylococcal (CoNS) species	16
Ocular surface microbiota dysbiosis contributes to the high prevalence of dry eye disease in diabetic patients	16
Bacterial kinase in ESKAPE pathogen: regulators of virulence and novel therapeutic targets	16
Insights into the molecular basis of c-di-GMP signalling in Pseudomonas aeruginosa	15
Review on computer-assisted biosynthetic capacities elucidation to assess metabolic interactions and communication within microbial communities	15
The potential for bacteriophages and prophage elements in fighting and preventing the gonorrhea	15
Porphyromonas gingivalis and the pathogenesis of Alzheimer’s disease	15
The crosstalk between SUMOylation and immune system in host-pathogen interactions	14
Community dynamics of subgingival microbiome in periodontitis and targets for microbiome modulation therapy	14
Anti-virulence peptides: a compromising strategy to treat Staphylococcus aureus chronic wound infection	14
Roles of alcohol dehydrogenase 1 in the biological activities of Candida albicans	13
Current and novel therapies for management of Acinetobacter baumannii -associated pneumonia	13
Mechanisms underlying the effects, and clinical applications, of oral microbiota in lung cancer: current challenges and prospects	13
Genetic basis of antibiotic resistance in bovine mastitis and its possible implications for human and ecological health	13
Aspergilli series Versicolores: importance of species identification in the clinical setting	13
Natural and synthetic molecules with potential to enhance biofilm formation and virulence properties in Pseudomonas aeruginosa	12
Type IV pilin regulation: a transcriptional overview	12
Phage-inspired strategies to combat antibacterial resistance	12
Ex vivo challenge models for infectious diseases	12
Antibiotic resistance genes in Escherichia coli – literature review	12
Friends and foes: impact of bacteria on genome stability	12
Marine microbial enzymes as potential antibiofilm agents: expanding the arsenal of bioactive agents targeting biofilm-forming microorganisms	12
Multiple potential strategies for the application of nisin and derivatives	11
Mycobacterium avium biofilms: mechanism of production, composition, and its role in pathogenesis and drug resistance	11
Towards the discovery of novel molecular clocks in Prokaryotes	11
The final gate: bacterial subversion of autophagosome-lysosome fusion as a conserved immune evasion strategy	11
Microparticles and nanoparticles-based approaches to improve oral treatment of Helicobacter pylori infection	11
Molecular imaging of bacterial biofilms—a systematic review	10
Rapid diagnosis and precision treatment of Helicobacter pylori infection in clinical settings	10
The complement system as a key modulator of the oral microbiome in health and disease	10
The therapeutic potential of phage-based antifungal treatment: strategies, mechanisms, and prospects	10
Virovory: control of viral pathogenesis by the protists and the way forward	10
Acinetobacter baumannii subunit vaccines: recent progress and challenges	10

How force drives pathogenicity: mechanoregulation of Streptococcus mutans adhesion to collagen	10
Peeling off the layers from microbial dark matter (MDM): recent advances, future challenges, and opportunities	9
Nasal microbiome dynamics: decoding the intricate nexus in the progression of respiratory and neurological diseases	9
Thermogenesis dynamics and influenza A virus: unveiling the intriguing interplay	9
Microbial bioemulsifiers as tools in biofilm disruption and prevention: state-of-the-art and emerging frontiers	9
Macrophage biology in the pathogenesis of Helicobacter pylori infection	8
Peptide-based strategies for overcoming biofilm-associated infections: a comprehensive review	8
Are anaerobic fungi crucial hidden players of microbiomes in anoxic environment?	8
Metabolomics in influenza viral infection: insights into host–virus interactions and potential biomarkers of severe outcomes	7
Blocking horizontal transfer of antibiotic resistance genes: an effective strategy in combating antibiotic resistance	7
Biofilm-associated Escherichia coli infections: pathogenesis, clinical implications, and treatment strategies	7
A comprehensive review of Bifidobacterium spp : as a probiotic, application in the food and therapeutic, and forthcoming trends	7
Selective pressures for public antibiotic resistance	7
Glycosylation orchestrates virulence and pathogenicity of periodontal keystone pathogens	7
The development and application of the Environmental Relative Moldiness Index (ERMI)	6
The battle within: how Pseudomonas aeruginosa uses host-pathogen interactions to infect the human lung	6
Insight into the multifactorial effect of climate change on marine bacteria: resilience mechanisms and mitigation strategies	6
Water and mosquitoes as key components of the infective cycle of Francisella tularensis in Europe: a review	6
Pathogenesis of leptospirosis-induced coagulopathy and hemorrhages	6
Non-antibiotic compounds associated with humans and the environment can promote horizontal transfer of antimicrobial resistance genes	6
Activation of host nucleic acid sensors by Mycobacterium : good for us or good for them?	6
Mycobacterium abscessus: insights from a bioinformatic perspective	5
Botanicals as promising antimicrobial agents for enhancing oral health: a comprehensive review	5
Anti-fungal peptides: an emerging category with enthralling therapeutic prospects in the treatment of candidiasis	5
Transformation of colitis and colorectal cancer: a tale of gut microbiota	5
The role of bacteriophage in inflammatory bowel disease and its therapeutic potential	5
A multifarious bacterial surface display: potential platform for biotechnological applications	5
Current developments and prospects of the antibiotic delivery systems	5
Long-Term effects of COVID-19: a review of current perspectives and mechanistic insights	5
Ferroptosis, from the virus point of view: opportunities and challenges	5
Evaluation of the antifungal effect of plant extracts on oral Candida spp. – a critical methodological analysis of the last decade	5
Interplay between lipid metabolism, lipid droplets and RNA virus replication	5